MAM-36 and ABILHAND as outcome measures of multiple sclerosis hand disability: an observational study

被引:1
|
作者
Prada, Valeria [1 ]
Tacchino, Andrea [2 ]
Podda, Jessica [2 ]
Pedulla, Ludovico [3 ]
Konrad, Giovanna [3 ]
Battaglia, Mario A. [4 ]
Brichetto, Giampaolo [2 ,3 ]
Monti Bragadin, Margherita [2 ,3 ]
机构
[1] Univ Genoa, Dept Neurosci, Genet & Maternal & Infantile Sci DINOGMI, Ophthalmol,Rehabil, Genoa, Italy
[2] Italian Multiple Sclerosis Soc Res Fdn FISM, Genoa, Italy
[3] AISM Rehabil Ctr, Italian Multiple Sclerosis Soc, Genoa, Italy
[4] Univ Siena, Dept Physiopathol, Expt Med & Publ Hlth, Siena, Italy
关键词
Outcome assessment; health care; Multiple sclerosis; Upper extremity; Neurodegenerative diseases; QUALITY-OF-LIFE; MANUAL ABILITY; PSYCHOMETRIC VALIDATION; EXPANDED DISABILITY; STATUS SCALE; FATIGUE; HEALTH; QUESTIONNAIRE; IMPAIRMENT; DEXTERITY;
D O I
10.23736/S1973-9087.20.06446-1
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
BACKGROUND: Impaired upper limb functionality and dexterity are common in people with multiple sclerosis (PwMS) and lead to increased dependency and reduced quality of life. AIM: The aim of this study was to compare the ability of the Manual Abilites Measure 36 (MAM-36) and the ABILHAND questionnaire to recognize an involvement of the upper limbs in PwMS, and to compare their results with those of other patient reported outcomes (PRO) evaluating disability, functional independence, symptoms of anxiety and depression, fatigue and quality of life. DESIGN: The study design was observational. SETTING: The setting of the study was outpatient. POPULATION: The study population included fifty-one PwMS (mean age of 56.31 years, age range of 33-82 years, 72.5% of patients were females). METHODS: For each patient were collected MAM-36, ABILHAND questionnaire, expanded disability status scale (EDSS), Functional Independence measure (FIM), Hospital Anxiety and Depression Scale (HADS), Modified Fatigue Impact Scale (MFIS) and Life Satisfaction Index (LSI). RESULTS : A strong correlation between MAM-36 and the ABILHAND questionnaire (Spearman r: 0.79; P<0.0001) were found. We obtained a significant correlation between MAM-36 and EDSS (Spearman r: -0.5; P=0.0002), FIM (Spearman r: 0.55; P<0.0001); we did not observe a correlation with MFIS (Spearman r: -0.33; P=0.02); moreover we found a similar trend between ABILHAND and EDSS (Spearman r: -0.47; P=0.0005), FIM (Spearman r: 0.61; P<0.0001), MFIS (Spearman r: -0.41; P=0.002). CONCLUSIONS: In PwMS the assessment of upper limbs is fundamental since it closely related to the level of disability of the person. Both MAM-36 and ABILHAND Questionnaire are equally able to detect upper limb dysfunctions in PwMS. CLINICAL REHABILITATION IMPACT : Both MAM-36 and ABILHAND can be used for upper limbs evaluation, within a multidimensional approach that seems to be the best way to evaluate PwMS.
引用
收藏
页码:520 / 526
页数:7
相关论文
共 50 条
  • [31] Outcome Measures in Clinical Trials for Multiple Sclerosis
    Caspar E. P. van Munster
    Bernard M. J. Uitdehaag
    CNS Drugs, 2017, 31 : 217 - 236
  • [32] Outcome Measures in Clinical Trials for Multiple Sclerosis
    van Munster, Caspar E. P.
    Uitdehaag, Bernard M. J.
    CNS DRUGS, 2017, 31 (03) : 217 - 236
  • [33] Clinical outcome measures in multiple sclerosis: A review
    Inojosa, Hernan
    Schriefer, Dirk
    Ziemssen, Tjalf
    AUTOIMMUNITY REVIEWS, 2020, 19 (05)
  • [34] Outcome measures in multiple sclerosis clinical trials
    Andersson, PB
    Goodkin, DE
    BAILLIERES CLINICAL NEUROLOGY, 1997, 6 (03): : 409 - 428
  • [35] The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study
    Fernandez, Oscar
    Papais Alvarenga, Marcos
    Guerrero, Miguel
    Leon, Antonio
    Alonso, Ana
    Carlos Lopez-Madrona, Jose
    Leyva, Laura
    Oliver, Begona
    de Ramon, Enrique
    Luque, Gloria
    Fernandez, Victoria
    MULTIPLE SCLEROSIS, 2011, 17 (02): : 192 - 197
  • [36] The test-retest reliability of outcome measures and their relationship to the Expanded Disability Status Scale in multiple sclerosis
    Brown, L.
    Metz, L. M.
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2008, 23 (06) : 744 - 744
  • [37] Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
    Lavery, Amy M.
    Verhey, Leonard H.
    Waldman, Amy T.
    MULTIPLE SCLEROSIS INTERNATIONAL, 2014, 2014
  • [38] Patient-Reported Outcome Measurement in Manual Ability for Multiple Sclerosis: Addressing the Targeting Issues of the ABILHAND
    Chen, Shih-Yin
    Pompilus, Farrah
    Strzok, Sara
    Cleanthous, Sophie
    Cano, Stefan
    Marquis, Patrick
    Cohan, Stanley
    Goldman, Myla
    Kresa-Reahl, Kiren
    Petrillo, Jennifer
    Castrillo-Viguera, Carmen
    Cadavid, Diego
    Mellion, Michelle
    NEUROLOGY, 2017, 88
  • [39] Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study
    Giordano, A.
    Pucci, E.
    Naldi, P.
    Mendozzi, L.
    Milanese, C.
    Tronci, F.
    Leone, M.
    Mascoli, N.
    La Mantia, L.
    Giuliani, G.
    Solari, A.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2009, 80 (09): : 1023 - 1028
  • [40] Outcome measures assisting treatment optimization in multiple sclerosis
    Pardo, Gabriel
    Coates, Samantha
    Okuda, Darin T.
    JOURNAL OF NEUROLOGY, 2022, 269 (03) : 1282 - 1297